Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy

Canadian Journal of Cardiology

Volumn 25, Issue 4, 2009, Pages 229-232

  Merkely, Bela ^a   Toth Zsamboki, Emese ^a   Becker, David ^a   Beres, Bernat Janos ^a   Szabó, György ^a   Vargova, Katarina ^a   Fülöp, Gabor ^a   Kerecsen, Gabor ^a   Preda, Istvan ^a   Spaulding, Christian ^b   Kiss, Robert Gabor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Institut Cochin   (France)

Author keywords

Myocardial infarction; Nonsteroidal anti inflammatory drugs; Platelet aggregation inhibitors; Stents; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CREATINE KINASE MB; DICLOFENAC; EPTIFIBATIDE; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; PROSTAGLANDIN SYNTHASE INHIBITOR; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE; TICLOPIDINE;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CASE REPORT; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; CORONARY ARTERY THROMBOSIS; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG ELUTING STENT; DRUG MEGADOSE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LUMBAR DISK HERNIA; MALE; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; STABLE ANGINA PECTORIS; THROMBOCYTE AGGREGATION; DIABETIC ANGIOPATHY; DRUG INTERACTION; INTERVERTEBRAL DISK HERNIA; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR ENDOTHELIUM;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY THROMBOSIS; CYCLOOXYGENASE INHIBITORS; DIABETIC ANGIOPATHIES; DICLOFENAC; DRUG INTERACTIONS; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; HUMANS; INTERVERTEBRAL DISK DISPLACEMENT; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THIAZINES; THIAZOLES; TICLOPIDINE; TIME FACTORS;

EID: 65349154484     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70073-X     Document Type: Letter

References (8)

1. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-68.
2. Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007;115:1051-8.
3. Henderson D, Gunalingam B. Very late stent thrombosis of a sirolimus-eluting stent. Catheter Cardiovasc Interv 2006;68:406-8.
4. Stone GW, Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008.
5. ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention; Smith SC Jr, Feldman TE, Hirshfeld JW Jr, eds. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006;113:el66-286.
6. Love MP Schampaert E, Cohen EA, et al; Canadian Association of Interventional. Cardiology; Canadian Cardiovascular Society. The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents. Can J Cardiol 2007;23:121-3.
7. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006;367:606-17.
8. Mitchell JA, Warner TD. COX isoforms in the cardiovascular system: Understanding the activities of non-steroidal anti-inflammatory drugs. Nat Rev Drug Discov 2006;5:75-86.